Quality Cancer Care for Life Act of 2010

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R. 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S. 1064, the Sun Act; S 965, the Family Act; H.R. 2954, Health Equity and Accountability Act of 2011; and H.R. 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R. 4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S. 2515, the Clean Cookstoves Support Act of 2012.

Client expense: $590,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R. 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S. 1064, the Sun Act; S 965, the Family Act; H.R. 2954, Health Equity and Accountability Act of 2011; and H.R. 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R. 4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act.

Client expense: $750,000 · Firm income: Not reported

Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493; HR 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010; S. 1064, the Sun Act; S. 965, the Family Act; HR 2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, and issues relating to the ongoing national shortage of cancer drugs.

Client expense: $360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S 494 and HR 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; HR 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; HR 1217, Repeal Prevention and Public Health Fund; HR 1740 and HR 5560, the Quality Cancer Care for Life Act of 2010; HR 2941 and S 3493; HR 3974, Viral Hepatatis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010; S 1064, the Sun Act; S 965, the Family Act; HR 2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act.

Client expense: $240,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; HR 2941 and S 3493; HR 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S. 1064, the Sun Act; S 965, the Family Act; HR2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, and issues relating to the ongoing national shortage of cancer drugs.

Client expense: $1,030,000 · Firm income: Not reported

Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S 494 and HR 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; HR 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; HR 1217, Repeal Prevention and Public Health Fund; HR 1740 and HR 5560, the Quality Cancer Care for Life Act of 2010; HR 2941 and S 3493; HR 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S. 1064, the Sun Act; S 965, the Family Act; HR2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act.

Client expense: $1,420,000 · Firm income: Not reported

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.494, and H.R.912; H.R.1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R.1217, Repeal Prevention & Public Health Fund; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493, H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.2366, the Cancer Drug Coverage Act of 2009; H.R.4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act, and H.R.2077, the MLR Repeal Act.

Client expense: $540,000 · Firm income: Not reported

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 494 and H.R. 912; H.R. 1213, repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, repeal Prevention & Public Health Fund; S. 488, the Access to Cancer Clinical Trials Act of 2009; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493, Johanna's Law reauthorization; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R. 2366, the Cancer Drug Coverage Act of 2009; H.R. 4662, the Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implemenatation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills (H.R. 5504, Improving Nutrition for America's Children Act, and S. 3307, Healthy, Hunger-Free Kids Act).

Client expense: $420,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation; H.R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 494 and H.R. 912; H.R. 1213, repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention & Public Health Fund; S. 488, The Access to Cancer Clinical Trials Act of 2009; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493, Johanna's Law reauthorization; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R. 2366, the Cancer Drug Coverage Act of 2009; H.R. 4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; and child nutrition reauthorization bills (H.R. 5504, Improving Nutrition for America's Children Act, and S. 3307, Healthy, Hunger-Free Kids Act).

Client expense: $380,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.494, and H.R.912; H.R.1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R.1217, Repeal Prevention & Public Health Fund; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493, Johanna's Law reauthorization; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.2366, the Cancer Drug Coverage Act of 2009; H.R.4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills (H.R.5504, Improving Nutrition for America's Children Act, and S.3307, Healthy, Hunger-Free Kids Act).

Client expense: $750,000 · Firm income: Not reported

Implementation of health insurance reform measures in comprehensive health reform including H.R.4872, Reconciliation Act of 2010 and H.R.3590, Patient Protection and Affordable Care Act. H.R. 901 and S.1624, The Medical Bankruptcy Fairness Act. H.R.5560, The Quality Cancer Care for Life Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

S 71 Telephone Excise Tax Repeal Act of 2009, support amending the Internal Revenue Service code of 1986 to repeal the excise tax on telephone and other communications services S 47 Telephone Excise Tax Repeal Act of 2009, support amending the Internal Revenue Service code of 1986 to repeal the excise tax on telephone and other communications services HR 3011 Telephone Excise Tax Repeal Act of 2009, support amending the Internal Revenue Service code of 1986 to repeal the excise tax on telephone and other communications services S 43 The Permanent Internet Tax Freedom Act of 2009, advocated in favor of permanent moratorium on Internet taxes HR 1560 The Permanent Internet Tax Freedom Act of 2009, advocated in favor of permanent moratorium on Internet taxes HR 691 The Broadband Access Equality Act of 2009, as it relates to credit against income tax for businesses furnishing broadband services to underserved and rural areas HR 422, Support extending the R&D tax credit through 2010 and to increase and make permanent the alternative simplified research credit HR 1521 The Cell Tax Fairness Act of 2009, support restrictions on any state or local jurisdiction from imposing a new discriminatory tax on cell phone services, providers or property S 1192 Mobile Wireless Tax Fairness Act of 2009, support restrictions on any state or local jurisdiction from imposing a new discriminatory tax on cell phone services, providers or property S 1203 Grow Research Opportunities with Taxcredits' Help Act (GROWTH Act), support provisions to to amend the Internal Revenue Code to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit HR 5649 Digital Goods and Services Tax Fairness Act of 2010, support legislation to establish a national framework to prevent multiple and discriminatory taxation of digital goods and services HR 5297 Small Business Jobs and Credit Act, provisions related to the extension of bonus depreciation and the delisting of cell phones as listed property HR 5560 Main Street Fairness Act, as it relates to tax provisions and tax simplification for communication services S 3793 Job Creation and Tax Cuts Act of 2010, as it relates to a one-year extension of expiring tax provisions including the R&D tax credit and changes to the tax treatment of "carried interest" HR 4853 Tax Relief, Unemployment Insurance Reauthorization and Job Creation Act of 2010, in support of extending bonus depreciation for corporations, the 15% tax rate for corporate dividends, the R&D tax credit and CFC look-through rules S 1447 Connecting America Act of 2009, provisions relating to broadband service providers

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.717, and H.R.6224, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493, Johanna's Law reauthorization; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.2366, the Cancer Drug Coverage Act of 2009; H.R.4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills (H.R.5504, Improving Nutrition for America's Children Act, and S.3307, Healthy, Hunger-Free Kids Act).

Client expense: $670,000 · Firm income: Not reported

Implementation of health insurance reform measures in comprehensive health reform including H.R.4872, Reconciliation Act of 2010 and H.R.3590, Patient Protection and Affordable Care Act. H.R. 901 and S.1624, The Medical Bankruptcy Fairness Act. H.R.5560, The Quality Cancer Care for Life Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues related to health disparities, health care reform, quality of life, federal helath care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R. 1189 Colorectal Cancer Early Detection, Prevention and Treatment Act; S. 717, and H.R. 6224, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S. 488, the Access to Cancer Trials Act of 2009; H.R. 1740 and H.R. 5560, the Quality Cancer Care of Life Act of 2010 and the implementation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010.

Client expense: $40,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.717, and H.R.6224, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills (H.R.5504, Improving Nutrition for America's Children Act, and S.3307, Healthy, Hunger-Free Kids Act).

Client expense: $1,110,000 · Firm income: Not reported

Implementation of health insurance reform measures in comprehensive health reform including H.R.4872, Reconciliation Act of 2010 and H.R.3590, Patient Protection and Affordable Care Act. H.R. 901 and S.1624, The Medical Bankruptcy Fairness Act. H.R. 5560, The Quality Cancer Care for Life Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R. 1189 Colorectal Cancer Early Detection, Prevention and Treatment Act; S. 717, and H.R. 6224, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S. 488, the Access to Cancer Clinical Trials Act of 2009; H.R. 1740 and H.R. 5560, the Quality Cancer Care of Life Act of 2010 and the implementation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Small business and internet sales tax issues including HR 5560 and third party liability issues relating to stolen goods.

Client expense: Not reported · Firm income: Not reported

Small business and internet sales tax issues including HR 5560 and third party liability issues relating to stolen goods.

Client expense: Not reported · Firm income: Not reported

Small business and internet sales tax issues including HR 5560 and third party liability issues relating to stolen goods.

Client expense: Not reported · Firm income: Not reported

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H. R. 756 & S. 660, National Pain Care Policy Act; H. R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 717, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S. 488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; and the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010..

Client expense: $450,000 · Firm income: Not reported